Suppl Information from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR<sup>+</sup>/HER2<sup>+</sup> Breast Cancer Patient-Derived Xenografts to Trastuzumab or FulvestrantPei-Yin Hsu, Shiuan Chen|Unknown|2023Cited by 0
Supplementary Figure Legends from Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish Noonepalle, Huidong Shi, Franklin Gu et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish Noonepalle, Huidong Shi, Franklin Gu et al.|Unknown|2023Cited by 0
Supplementary Figure S6 from Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish Noonepalle, Huidong Shi, Franklin Gu et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish Noonepalle, Huidong Shi, Franklin Gu et al.|Unknown|2023Cited by 0